Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: LY3214996 +/- HCQ in Pancreatic Cancer [Phase 2]
Phase 2 trial of LY3214996 with or without hydroxychloroquine in pancreatic cancer completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer [Phase 1]
Phase 1 study evaluating talimogene laherparepvec (T-VEC) in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial update of a three-drug combination (erlotinib, gemcitabine, nab-paclitaxel) in advanced pancreatic cancer; the study has compl…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Virtual Mind-Body Exercises for People Having Pancreatic Surgery [NA]
A clinical trial sponsored by Memorial Sloan Kettering Cancer Center studied virtual mind-body exercises for people undergoing pancreatic su…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and dosimetry of gallium-68 labelled OncoFAP derivatives in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer [Phase 1]
This is a Phase 1 open-label study evaluating ONO-7913 and ONO-4538 in combination with modified FOLFIRINOX as first-line therapy for metast…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver [Phase 1]
This Phase 1 study evaluates the combination of radiation therapy and chemotherapy for pancreatic cancer with homologous recombination defic…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial of ganitumab in locally advanced unresectable pancreatic cancer has been terminated; results were posted on 2024-11-08.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer [Phase 2, Phase 3]
A randomized Phase 2/3 multi-center trial of SM-88 for metastatic pancreatic cancer was terminated, with results posted on 2024-11-06.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 3]
A Phase 3 neoadjuvant trial evaluating pamrevlumab in combination with chemotherapy (gemcitabine plus nab-paclitaxel or FOLFIRINOX) for loca…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions
A completed observational study in Japan evaluated the real-world use of gadoxetate disodium-enhanced MRI (EOB-MRI) to diagnose metastatic s…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial of CCT301-59 CAR T therapy in adults with recurrent or refractory solid tumors has been terminated. The study included soft ti…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]
Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and cape…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for QUILT-2.019, a Phase 1/2 study of AMG-655 or AMG-479 with gemcitabine for metastatic pancreatic cancer, with resul…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Differentiation Benign and Malignant Pancreatic Lesions
The clinical trial update reports the completed study evaluating methods to differentiate benign versus malignant pancreatic lesions.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Pancreatic Cancer Early Detection Registry
The Pancreatic Cancer Early Detection Registry trial (NCT05519930) has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating palliative stereotactic radiation therapy for pancreatic cancer and periampullary adenocarcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
APN401 was evaluated in a Phase 1 trial for patients with recurrent or metastatic pancreatic cancer, colorectal cancer, and unresectable sol…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients [Phase 2]
A Phase 2 trial evaluating immunologic effects of CDX-301 and CDX-1140 in resectable pancreatic cancer has been terminated, and results have…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade
This clinical trial update reports long-term survival outcomes in pancreatic cancer patients treated with neoadjuvant therapy, evaluating re…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Olaparib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated olaparib in patients with Stage IV pancreatic cancer, and results have been posted.